Serving Encino, CA

GIST Specialist for Encino, CA

Being told a tumor is too large, or that removing it means removing most of your stomach, is not always the final word. Targeted therapy can shrink a gastrointestinal stromal tumor into a far smaller operation. Joshua Ellenhorn, MD, FACS decides when that applies.

  • Second opinions on tumors described as inoperable or borderline
  • Clinical Professor of Surgery, Cedars-Sinai Medical Center
  • Neoadjuvant imatinib sequencing, timed to the point of maximum response
  • Remote imaging review before you cross the hill
Large gastrointestinal stromal tumor assessment and treatment for Encino, CA patients
3-9 moTypical course of imatinib before surgery in responsive tumors
Exon 11The KIT mutation most likely to respond well
LiverThe usual site of spread, and a reason to stage properly first
30 minFrom Ventura Boulevard, over Coldwater Canyon
The sequencing question

Sometimes the Best First Move Is Not Surgery

Surgery cures GIST. That does not mean surgery should always come first. For a bulky tumor, or one pressing against the pancreas, the spleen, or the gastroesophageal junction, operating immediately can mean removing far more than the disease requires.

Imatinib changes that. In tumors with a responsive mutation, three to nine months of treatment can shrink the mass substantially, pulling it away from the structures it was abutting. An operation that would have taken most of the stomach becomes a wedge. A resection that looked to involve neighbouring organs becomes a clean, contained one.

The judgment is in the timing. Operate too early and the benefit is wasted. Continue past the plateau, usually visible on serial imaging, and you are delaying the curative step for no gain. That window is narrow and it is easy to miss without experience of watching tumors respond.

Which is also why mutation testing comes first. A PDGFRA D842V or wild type tumor is unlikely to shrink, and months spent discovering that are months lost. Knowing which category you are in before starting is the entire point.

GIST specialist assessing a large tumor on imaging in Los Angeles
Anatomy of a large gastrointestinal stromal tumor in the stomach wall
The disease

What a Gastrointestinal Stromal Tumor Is

GIST develops from the interstitial cells of Cajal, pacemaker cells inside the wall of the digestive tract that coordinate the contractions moving food along. It is a sarcoma, and it does not behave like the carcinomas that account for most gastrointestinal cancer.

Because these tumors grow outward from the wall rather than into the passage, they can become genuinely large before causing symptoms. Patients are often surprised at the size of something they had no inkling of. That outward growth is also why they seldom involve lymph nodes, and why removal with a clear margin, rather than a wide anatomical clearance, is what constitutes a cure.

Nearly all carry a driver mutation in KIT, a minority in PDGFRA. That mutation is both the reason the tumor grows unchecked and the reason a tablet can shrink it. Which specific mutation you have determines whether that tablet will work at all.

Staging

Before Anything, Establish the Full Picture

For a large tumor, staging is not a formality. Contrast CT of the abdomen and pelvis defines the tumor and its relationships, and looks for liver deposits, which are the commonest site of spread. PET/CT is particularly useful here because it also gives an early read on whether a tumor is responding once treatment starts, often well before it visibly shrinks.

Biopsy with mutation testing is generally necessary when medication is being considered, and endoscopic ultrasound guided sampling is the controlled way to obtain it. The caution is real: rupturing the capsule of a large tumor can seed the abdominal cavity, so who takes the sample and how matters.

Bring or send whatever your Encino physician has already ordered. For bulky tumors the actual imaging study is far more useful than the written report, because the surgical question is about millimetres of contact with adjacent structures.

CT and PET imaging staging a gastrointestinal stromal tumor
The pathway

How a Large Tumor Is Actually Handled

Three phases, and the skill lies in judging when to move between them.

Phase one

Stage and Genotype

Full imaging plus a biopsy with mutation testing. This establishes whether the tumor will respond to imatinib and whether disease has already reached the liver. Everything downstream depends on these two answers.

Phase two

Shrink It

Imatinib for three to nine months in responsive tumors, with serial imaging to track the response. The aim is the point of maximum shrinkage, which is when the operation is smallest and safest.

Phase three

Remove It

Resection at the optimal moment, frequently far more limited than what was originally proposed. Adjuvant therapy usually continues afterwards, since a large tumor carries higher recurrence risk regardless of how well it responded.

In the operating room

The Operations, Recorded

Real GIST resections narrated by the surgeon who performed them. Worth watching if you are trying to understand what a limited resection actually involves compared with what may have been proposed to you.

Laparoscopic Resection of a Gastric GIST

A gastric GIST removed through small incisions with the capsule intact.

Gastric GIST Resection: A Simplified Approach

A streamlined approach that shortens operating time and recovery.

Robotic Resection of a Duodenal GIST

Duodenal GIST in confined anatomy, removed robotically with the pancreas and bile duct preserved.

If you have been told inoperable

Get It Read Again

Unresectable and not yet resectable are very different conclusions, and the second one often changes after a few months of the right drug. Before accepting the first, have the imaging and mutation status reviewed by someone who sequences these routinely.

Credentials

Credentials and Licensure

Two American Board of Surgery certifications, a Cedars-Sinai teaching appointment, and membership of the societies that set standards for this disease.

Cedars-Sinai Medical CenterFellow of the American College of SurgeonsSociety of Surgical OncologyAmerican Society of Clinical OncologySuper Doctors recognition
  • American Board of Surgery, certified in General Surgery
  • American Board of Surgery, certified in Colorectal Surgery
  • California State Medical License
  • Florida State Medical License
Your surgeon

Joshua Ellenhorn, MD, FACS

Dr. Ellenhorn is a surgical oncologist and Clinical Professor of Surgery at Cedars-Sinai Medical Center, and a collaborative member of the Samuel Oschin Comprehensive Cancer Institute. He is widely regarded as one of the foremost GIST surgeons in the country.

His practice is deliberately narrow, concentrating on complex abdominal cancers and gastrointestinal stromal tumors. Bulky and borderline resectable tumors are a substantial part of that work, which is where the sequencing of drug therapy and surgery has the greatest effect on the eventual operation.

He is certified by the American Board of Surgery in General Surgery and Colorectal Surgery, a Fellow of the American College of Surgeons, and a member of the Society of Surgical Oncology and the American Society of Clinical Oncology. He practises with the Surgery Group of Los Angeles.

Dr. Joshua Ellenhorn, MD, FACS, GIST surgeon serving Encino, CA
Patient experience

What Patients Say About Dr. Ellenhorn

Reviews left by patients treated by Dr. Ellenhorn at the Surgery Group of Los Angeles.

★★★★★

The staff at the Surgery Group of Los Angeles are wonderful. They are kind, very attentive, the office is clean and I did not have to wait long at all. I cannot say enough great things about Dr. Ellenhorn. He is an excellent surgeon who is highly skilled and very knowledgeable. I cannot thank him enough for all he has done for my family and I.

Erika Frank
★★★★★

Very kind stuff, great service. Dr Joshua Ellenhorn is a very calm doctor who takes time with his patient.

Anita Lukacevic
What to expect

From Bulky Tumor to Smaller Operation

01

Send the Study, Not Just the Report

Call (310) 356-3792 or book online, then forward the actual CT or PET imaging along with pathology and mutation results. For large tumors the images carry information the report does not.

02

Agree the Sequence

You should leave knowing whether surgery comes now or after medication, what response would be needed to change the operation, and when the imaging checkpoints fall.

03

Operate at the Right Moment

Resection timed to maximum response, with your Encino oncologist managing the drug throughout and receiving the operative findings afterwards.

Getting here

Thirty Minutes From Ventura Boulevard

Ventura Boulevard east to Coldwater Canyon, over the hill to Beverly Drive and east to 3rd Street, is the standard route from Encino. The 101 east to Laurel Canyon and south is the alternative. Either canyon adds time during the morning and evening peaks, so allow closer to thirty five minutes then.

The office is in the medical plaza attached to Cedars-Sinai Medical Center, which for a patient managing staging scans, oncology visits, and eventually surgery means one destination rather than several. Given the drive from the west Valley, that consolidation is worth more here than it is closer in.

If crossing the hill repeatedly is impractical, imaging and pathology can be reviewed remotely and much of the planning done before you travel at all.

GIST Specialist

8635 W 3rd St, Suite 880W
Los Angeles, CA 90048

(310) 356-3792

Monday to Saturday, 11:00am to 8:00pm
Closed Sunday

Encino patient questions

Frequently Asked Questions

My tumor is large. Does that mean it is inoperable?
Rarely. Size alone seldom makes a GIST unresectable. What matters is what the tumor is attached to and whether it can be removed intact. Many tumors described elsewhere as too large become straightforward after several months of imatinib, which is why an opinion before accepting inoperability is worth having.
What does neoadjuvant imatinib actually do?
It blocks the mutated KIT or PDGFRA signal driving growth, and in responsive tumors it shrinks them substantially over three to nine months. That can turn a resection requiring removal of most of the stomach into a wedge, or free a tumor from a structure it was pressing against.
How long would I be on medication before surgery?
Usually somewhere between three and nine months, with imaging along the way to confirm response and identify the point of maximum benefit. Operating too early wastes the opportunity, and continuing past the plateau delays the cure without adding anything.
What if the tumor does not respond to the drug?
That happens, most often with PDGFRA D842V and wild type tumors, which is exactly why mutation testing comes before treatment rather than after. If the tumor is not going to respond, the plan moves to surgery directly rather than losing months finding out.
Is a large GIST more likely to have spread?
Larger tumors carry higher risk, and the liver is the usual site. That is one reason staging imaging matters before any operation. Finding liver disease changes the sequence, though it does not necessarily rule out surgery later once the drug has taken effect.
How far is your office from Encino?
Twenty five to thirty minutes. Ventura Boulevard east to Coldwater Canyon and over the hill is the usual route, or the 101 to Laurel Canyon. Allow extra during the morning and evening peaks over either canyon.
Can my imaging be reviewed before I drive over the hill?
Yes, and for a bulky tumor that is often the sensible first step. Send the CT or PET and the pathology, and you will get a view on whether surgery, medication first, or further staging is the right next move.
Will my Encino oncologist stay involved?
Yes. If neoadjuvant imatinib is part of the plan, they typically prescribe and monitor it while the surgical timing is judged here. Imaging and reports move between both sides so the decision to operate is made on shared information.

Too Large Today Does Not Mean Too Large in Six Months.

If you have been told a gastrointestinal stromal tumor is inoperable or requires a major resection, the mutation status and a course of targeted therapy may change that entirely. Have it reviewed first.

Call Now